37 related articles for article (PubMed ID: 10026840)
1. Oxytocin and vasopressin constrict rat isolated uterine resistance arteries by activating vasopressin V1A receptors.
Chen YL; Shepherd C; Spinelli W; Lai FM
Eur J Pharmacol; 1999 Jul; 376(1-2):45-51. PubMed ID: 10440088
[TBL] [Abstract][Full Text] [Related]
2. Effect of the non-peptide, vasopressin V1a receptor antagonist, SR 49059 and its enantiomer, SR 49770, on isolated human myometrium.
Bossmar T; Rasmussen T; Akerlund M
Acta Obstet Gynecol Scand; 1996 Jul; 75(6):516-9. PubMed ID: 8693925
[TBL] [Abstract][Full Text] [Related]
3. Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women.
Akerlund M; Bossmar T; Brouard R; Kostrzewska A; Laudanski T; Lemancewicz A; Serradeil-Le Gal C; Steinwall M
Br J Obstet Gynaecol; 1999 Oct; 106(10):1047-53. PubMed ID: 10519430
[TBL] [Abstract][Full Text] [Related]
4. Evidence for an involvement of vasopressin in mechanism of primary dysmenorrhea and effect of the non-peptide vasopressin V1a receptor antagonist, SR 49059, on the uterus of non-pregnant women.
Akerlund M; Bossmar T; Brouard R; Steinwall M
Adv Exp Med Biol; 1998; 449():467-72. PubMed ID: 10026840
[No Abstract] [Full Text] [Related]
5. Involvement of oxytocin and vasopressin in the pathophysiology of preterm labor and primary dysmenorrhea.
Akerlund M
Prog Brain Res; 2002; 139():359-65. PubMed ID: 12436949
[TBL] [Abstract][Full Text] [Related]
6. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.
Akerlund M; Melin P; Maggi M
Adv Exp Med Biol; 1995; 395():595-600. PubMed ID: 8714023
[TBL] [Abstract][Full Text] [Related]
7. Vasopressin and oxytocin in normal reproduction and in the pathophysiology of preterm labour and primary dysmenorrhoea. Development of receptor antagonists for therapeutic use in these conditions.
Akerlund M
Rocz Akad Med Bialymst; 2004; 49():18-21. PubMed ID: 15631309
[TBL] [Abstract][Full Text] [Related]
8. Vasopressin receptor antagonists: pharmacological tools and potential therapeutic agents.
Streefkerk JO; van Zwieten PA
Auton Autacoid Pharmacol; 2006 Apr; 26(2):141-8. PubMed ID: 16553642
[TBL] [Abstract][Full Text] [Related]
9. Vasopressin antagonists.
Lemmens-Gruber R; Kamyar M
Cell Mol Life Sci; 2006 Aug; 63(15):1766-79. PubMed ID: 16794787
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
